O'Connor Donal has filed 16 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 24258 shares of Theravance Biopharma, Inc. ($TBPH) on May 19, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 19, 2025 | Theravance Biopharma, Inc. | $TBPH | O'Connor Donal | Not found | A | Share Option (Right to Buy) | 24258 | $0.00 | 24,258.0000 | 49,706,000 | 9999.99% | 0.05% |
| May 19, 2025 | Theravance Biopharma, Inc. | $TBPH | O'Connor Donal | Not found | A | Ordinary Shares | 10649 | $0.00 | 74,204.0000 | 49,706,000 | 16.76% | 0.02% |
| May 14, 2025 | PERRIGO Co plc | $PRGO | O'Connor Donal | Director | A | Restricted Stock Units | 7305 | $0.00 | 7,305.0000 | 137,400,000 | 9999.99% | 0.01% |
| May 14, 2025 | PERRIGO Co plc | $PRGO | O'Connor Donal | Director | M | Restricted Stock Units | 9904 | $0.00 | 0.0000 | 137,400,000 | 100.00% | 0.01% |
| May 14, 2025 | PERRIGO Co plc | $PRGO | O'Connor Donal | Director | M | Ordinary Shares | 9904 | $26.01 | 36,589.0000 | 137,400,000 | 37.11% | 0.01% |
| May 14, 2025 | PERRIGO Co plc | $PRGO | O'Connor Donal | Director | F | Ordinary Shares | 4754 | $26.01 | 31,835.0000 | 137,400,000 | 12.99% | 0.00% |
| May 14, 2024 | PERRIGO Co plc | $PRGO | O'Connor Donal | Director | A | Restricted Stock Units | 9904 | $0.00 | 9,904.0000 | 135,300,000 | 9999.99% | 0.01% |
| May 15, 2024 | PERRIGO Co plc | $PRGO | O'Connor Donal | Director | M | Restricted Stock Units | 8764 | $0.00 | 0.0000 | 135,300,000 | 100.00% | 0.01% |
| May 15, 2024 | PERRIGO Co plc | $PRGO | O'Connor Donal | Director | F | Ordinary Shares | 4207 | $30.22 | 25,487.0000 | 135,300,000 | 14.17% | 0.00% |
| May 15, 2024 | PERRIGO Co plc | $PRGO | O'Connor Donal | Director | M | Ordinary Shares | 8764 | $30.22 | 29,694.0000 | 135,300,000 | 41.87% | 0.01% |
| May 8, 2024 | Theravance Biopharma, Inc. | $TBPH | O'Connor Donal | Not found | A | Ordinary Shares | 10537 | $0.00 | 63,555.0000 | 48,283,000 | 19.87% | 0.02% |
| May 8, 2024 | Theravance Biopharma, Inc. | $TBPH | O'Connor Donal | Not found | A | Share Option (Right to Buy) | 23576 | $0.00 | 23,576.0000 | 48,283,000 | 9999.99% | 0.05% |
| May 17, 2023 | PERRIGO Co plc | $PRGO | O'Connor Donal | Director | M | Ordinary Shares | 7778 | $32.86 | 25,862.0000 | 134,500,000 | 43.01% | 0.01% |
| May 17, 2023 | PERRIGO Co plc | $PRGO | O'Connor Donal | Director | F | Ordinary Shares | 3734 | $32.86 | 22,128.0000 | 134,500,000 | 14.44% | 0.00% |
| May 17, 2023 | PERRIGO Co plc | $PRGO | O'Connor Donal | Director | M | Restricted Stock Units | 7778 | $0.00 | 0.0000 | 134,500,000 | 100.00% | 0.01% |
| May 15, 2023 | PERRIGO Co plc | $PRGO | O'Connor Donal | Director | A | Restricted Stock Units | 8764 | $0.00 | 8,764.0000 | 134,500,000 | 9999.99% | 0.01% |